コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n, body mass index, waist circumference, and waist:hip ratio).
2 ncluding height, weight, body-mass index and waist-hip ratio.
3 e increased continuously across the range of waist-hip ratio.
4 1.08, 1.87, and 1.68 (p for trend=0.06) for waist/hip ratio.
5 al-energy X-ray absorptiometry than with the waist/hip ratio.
6 th SBP, pulse pressure, heart rate, BMI, and waist/hip ratio.
7 rrelated closely with body mass index and/or waist/hip ratio.
8 ly associated with body mass index (BMI) and waist/hip ratio.
9 ciation with height, waist circumference, or waist/hip ratio.
10 ull after adjustment for body mass index and waist:hip ratio.
11 ding a measure of body fat distribution, the waist:hip ratio.
12 st-hip ratio [the strongest of which was the waist-hip ratio (-0.13-SD change; 95% CI: -0.20-, -0.07-
15 d pressure (DBP), body mass index (BMI), and waist/hip ratio, after adjusting for age, sex, and heigh
16 ciated with higher BMI, waist circumference, waist-hip ratio, alanine transaminase, white blood cell
17 ns of breast cancer with body mass index and waist/hip ratio among Black women are similar to those d
19 waist-hip ratio and physical activity, both waist-hip ratio and physical activity were significant p
21 uthors previously reported an interaction of waist/hip ratio and family history on the risk of breast
22 and after accounting for age, hypertension, waist/hip ratio and lipid and sugar levels, fibrinogen s
23 intake was inversely associated with age and waist/hip ratio and positively associated with alcohol c
25 n-American women by 20%; adjustment for both waist:hip ratio and severe obesity reduced the odds rati
26 eight, body mass index, waist circumference, waist : hip ratio, and subscapular skinfold thickness we
27 ect of body mass index, waist circumference, waist-hip ratio, and 10-year weight change on the risk o
28 ist circumference, 2.4 (95% CI, 1.6-3.5) for waist-hip ratio, and 3.8 (95% CI, 2.6-5.5) for waist-hei
29 s influenced independently by age, sex, BMI, waist-hip ratio, and serum cholesterol concentration.
31 circumference, 1.11 (95% CI, 1.08-1.14) for waist/hip ratio, and 1.22 (95% CI, 1.17-1.27) for body m
32 dy mass index, 1.46 (95% CI: 0.73, 2.92) for waist/hip ratio, and 2.40 (95% CI: 1.24, 4.63) for heigh
34 Adjusted for age, smoking, body mass index, waist/hip ratio, and estrogen use, the relative risk of
37 unique evidence of ID for handgrip strength, waist/hip ratio, and visual and auditory acuity (ID betw
38 adjusted for age, body mass index, diabetes, waist/hip ratios, and levels of glycated hemoglobin, the
39 s in body mass, BMI, percentage of body fat, waist:hip ratio, and leptin in the LGI-diet group than i
40 idence suggests that waist circumference and waist-hip ratio, as indicators of abdominal adiposity, a
41 king status, triglycerides, type 2 diabetes, waist-hip ratio, attention deficit hyperactivity disorde
43 ment for age, sex, smoking, body mass index, waist/hip ratio, blood glucose, triglycerides, cholester
44 etes, hypertension, smoking and alcohol use, waist:hip ratio, BMI, LDL cholesterol concentration, log
45 infold-thickness and circumference measures, waist-hip ratio, body mass index, total body mass, fat m
46 e, which persisted after adjustment for age, waist/hip ratio, body mass index, alcohol intake, cigare
47 trongly related to FFM than to adipose mass, waist/hip ratio, body mass index, or height-based surrog
48 to <0.001) than they were with adipose mass, waist/hip ratio, body mass index, systolic blood pressur
49 men and was independently related to FFM and waist/hip ratio (both P<0.001) but not to body mass inde
50 king status, triglycerides, type 2 diabetes, waist-hip ratio, childhood cognitive ability, neuroticis
52 res of fatness including body mass index and waist/hip ratio, current asthma, and specific skin prick
53 ne clearance, hypertension, body mass index, waist-hip ratio, DCCT treatment group, smoking status.
55 riglyceride levels), percentage of body fat, waist-hip ratio, fasting insulin and glucose levels, and
56 hin was positively correlated with age, BMI, waist/hip ratio, FBG, HbA1C, HOMA-IR and TG in the non-d
57 er body mass index, waist circumference, and waist-hip ratio gave RRs of 1.22 (95% confidence interva
58 (women/men) waist circumference >94/95 cm or waist: hip ratio >0.88/0.94 received open-label telmisar
59 e, but the highest effect estimates were for waist/hip ratio (hazard ratio = 1.56, 95% confidence int
60 ered, the joint addition of body mass index, waist:hip ratio, high density lipoprotein cholesterol, a
61 stment for the confounders of smoking, race, waist/hip ratio, hypertension, and duration of diabetes.
64 001) and body mass index (P=0.02) but not to waist/hip ratio in men and was independently related to
66 ignificantly associated with an even greater waist:hip ratio in severely stunted females (p = 0.03).
67 S) for schizophrenia, bipolar disorder, BMI, waist-hip-ratio, insulin resistance and height, as well
69 orted interaction between family history and waist/hip ratio is still (weakly) evident and appears to
70 insulin sensitivity when accounting for the waist:hip ratio (Matsuda index unadjusted, P < 0.001 for
73 ificant decreases in waist circumference and waist:hip ratio occurred (both p<0.001) without BMI or w
74 those with higher physical activity and low waist/hip ratio (odds ratio = 0.37, 95% CI: 0.18, 0.75)
75 gnificantly greater adult abdominal fatness (waist:hip ratio), once overall fatness and confounders w
77 were greatly attenuated when we adjusted for waist-hip ratio or waist circumference and other covaria
81 for men vs women, 4.12; 95% CI, 2.29-7.43), waist-hip ratio (OR per 0.1 unit increase, 1.61; 95% CI,
82 interval (CI): 1.2, 1.4; per 1.4 mg/dl) and waist/hip ratio (OR = 1.4, 95% CI: 1.2, 1.5; per 0.08) a
85 nfounders age, sex, systolic blood pressure, waist:hip ratio, or body mass index (BMI) and corrected
88 tely 2.5 microU/mL per 0.08 unit increase in waist/hip ratio (p < 0.05), although this association wa
89 ssociated with body mass index (p < 0.0001), waist/hip ratio (p = 0.02), and glucose intolerance (p =
90 ceptive use, and changes in body mass index, waist-hip ratio, physical activity, smoking status, and
91 e logistic regression models, adjustment for waist:hip ratio reduced the odds ratio for later-stage d
92 physical activity and the highest tertile of waist-hip ratio (relative risk=3.03; 95% CI, 1.96 to 4.1
93 e of genetic heterogeneity between sexes for waist-hip ratio (rg = approximately 0.7) and between pop
94 kg)/height (m)(2)), waist circumference, and waist:hip ratio) single-nucleotide polymorphisms (SNPs)
95 Measurements were made of height, weight, waist:hip ratio, skin, hair, and eye color, blood pressu
96 er adjustment for age, sex, body mass index, waist/hip ratio, smoking status, ethanol intake, educati
97 gender, income, ethnicity, body mass index, waist/hip ratio, smoking, paid employment, time of wakin
98 egression, after adjustment for age, gender, waist/hip ratio, systolic blood pressure, and diabetes m
100 tolic blood pressure, triglycerides, and the waist-hip ratio [the strongest of which was the waist-hi
102 ge, sex, body mass index, smoking, exercise, waist-hip ratio, TV viewing, and study site, there was a
103 s used included weight, waist circumference, waist:hip ratio, waist:height ratio, abdominal height, t
104 of obesity, measured using body mass index, waist:hip ratio, waist:height ratio, and waist circumfer
106 usted relative risk for extreme quintiles of waist/hip ratio was 2.33 (95% confidence interval 1.25-4
108 ear trend of increasing risk with increasing waist/hip ratio was observed among family history-positi
111 a Breast Study found that obesity (increased waist/hip ratio) was linked to an increased incidence of
112 oking, body mass index, waist circumference, waist-hip ratio, weight gain, less physical activity, an
113 s (95% CI) of the top versus bottom fifth of waist-hip ratio were 1.55 (1.28 to 1.73) in men and 1.91
114 , and 2.15 (p for trend=0.27), and those for waist/hip ratio were 1.0, 2.07, 2.33, and 4.22 (p for tr
115 -positive women in the upper quintile of the waist/hip ratio were at 2.2-fold greater risk of progest
116 lts for a one-standard-deviation increase in waist:hip ratio were 13.96 (95% CI: 10.44, 17.48) for AL
118 by computed tomography scan at L4-L5 and the waist-hip ratio) were determined before and after traini
120 tion to higher body mass index (BMI), WC, or waist-hip ratio (WHR) interacts with dietary calcium in
122 nvestigated the relations of waist girth and waist-hip ratio (WHR) to CAC in 2951 African American an
123 index (BMI) (weight (kg)/height (m)(2)) and waist-hip ratio (WHR)) with breast cancer-specific and a
124 of adiposity [ie, waist circumference (WC), waist-hip ratio (WHR), FM, and %BF] were significantly a
125 ty, measured by waist circumference (WC) and waist-hip ratio (WHR), have been previously identified,
126 uch as body mass index, waist circumference, waist-hip ratio (WHR), high- and low-density lipoprotein
127 central adiposity [waist circumference (WC), waist-hip ratio (WHR), or waist-height ratio (WHtR)] and
128 Totally, 32 body mass index (BMI)- and 14 waist-hip ratio (WHR)-associated single nucleotide polym
131 the relative risk for the 90th percentile of waist: hip ratio (WHR) (WHR = 0.86) versus the 10th perc
132 defined by increased waist circumference or waist:hip ratio (WHR), is associated with increased card
133 ion of central (waist circumference [WC] and waist-hip ratio [WHR]) and total obesity (body mass inde
134 veness (male waist-chest ratio [WCR], female waist-hip ratio [WHR], and volume-height index [VHI] in
136 on of body mass index and abdominal obesity (waist/hip ratio) with stroke incidence was examined in 2
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。